Tikun Olam-Cannbit Pharmaceuticals Ltd
TLV: TKUN.TA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tel Aviv Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ronen Elad
- Employees
- 19
- Headquarters
- Nof HaGalil, Israel
- IPO year
- 2002
- Market cap
- ILA 16.0M
- Website
- https://www.tikun-olam.org.il
Loading TKUN…
Loading profile data…Frequently asked questions about TKUN
What does Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA) do?
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the research, development, cultivation, manufacture, and distribution of medical cannabis and related products. It also provides training and patient care services. The company is based in Nof Hagalil, Israel.
Where does TKUN.TA trade?
Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA) trades on the Tel Aviv Stock Exchange.
What sector is TKUN.TA in?
Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tikun Olam-Cannbit Pharmaceuticals Ltd?
Ronen Elad is the chief executive officer of Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA).
Where is Tikun Olam-Cannbit Pharmaceuticals Ltd headquartered?
Tikun Olam-Cannbit Pharmaceuticals Ltd is headquartered in Israel.
Does TKUN.TA pay a dividend?
Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TKUN.TA go public?
Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA) completed its initial public offering in 2002.